NGNE vs. META

Last updated Apr 1, 2026

Compare and contrast key facts about Neurogene Inc (NGNE) and Meta Platforms, Inc. (META).

Performance

NGNE vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neurogene Inc (NGNE) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

NGNE vs. META - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NGNE Neurogene Inc	-2.14%	-9.89%	17.96%	90.37%	-89.44%	-65.82%	14.45%	470.37%	-81.63%	-28.77%
META Meta Platforms, Inc.	-13.25%	13.09%	66.05%	194.13%	-64.22%	23.13%	33.09%	56.57%	-25.71%	53.38%

Fundamentals

Market Cap NGNE : $312.27M META : $1.47T
EPS NGNE : -$4.70 META : $23.51
PB Ratio NGNE : 1.18 META : 6.78
Total Revenue (TTM) NGNE : $0.00 META : $200.97B
Gross Profit (TTM) NGNE : -$787.00K META : $164.79B
EBITDA (TTM) NGNE : -$90.05M META : $104.55B

Returns By Period

In the year-to-date period, NGNE achieves a -2.14% return, which is significantly higher than META's -13.25% return. Over the past 10 years, NGNE has underperformed META with an annualized return of -20.18%, while META has yielded a comparatively higher 17.39% annualized return.

NGNE

• 1D: 4.46%
• 1M: -14.18%
• YTD: -2.14%
• 6M: 16.33%
• 1Y: 72.16%
• 3Y*: 12.92%
• 5Y*: -39.64%
• 10Y*: -20.18%

META

• 1D: 6.67%
• 1M: -11.66%
• YTD: -13.25%
• 6M: -21.96%
• 1Y: -0.42%
• 3Y*: 39.60%
• 5Y*: 14.06%
• 10Y*: 17.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NGNE vs. META — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NGNE

NGNE Risk / Return Rank: 64
NGNE Sharpe Ratio Rank: 65
NGNE Sortino Ratio Rank: 73
NGNE Omega Ratio Rank: 67
NGNE Calmar Ratio Rank: 57
NGNE Martin Ratio Rank: 55

META

META Risk / Return Rank: 40
META Sharpe Ratio Rank: 41
META Sortino Ratio Rank: 38
META Omega Ratio Rank: 37
META Calmar Ratio Rank: 42
META Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NGNE vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neurogene Inc (NGNE) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NGNE	META	Difference
Sharpe ratio Return per unit of total volatility	0.68	-0.01	+0.69
Sortino ratio Return per unit of downside risk	1.75	0.29	+1.47
Omega ratio Gain probability vs. loss probability	1.20	1.04	+0.16
Calmar ratio Return relative to maximum drawdown	0.74	-0.01	+0.76
Martin ratio Return relative to average drawdown	1.37	-0.04	+1.41
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NGNE vs. META - Sharpe Ratio Comparison

The current NGNE Sharpe Ratio is 0.68, which is higher than the META Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of NGNE and META, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NGNE	META	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.68	-0.01	+0.69
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.43	0.32	-0.75
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.23	0.45	-0.68
Sharpe Ratio (All Time) Calculated using the full available price history	-0.11	0.55	-0.66

Correlation

The correlation between NGNE and META is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NGNE vs. META - Dividend Comparison

NGNE has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.37%.

	TTM	2025	2024
NGNE Neurogene Inc	0.00%	0.00%	0.00%
META Meta Platforms, Inc.	0.37%	0.32%	0.34%

Drawdowns

NGNE vs. META - Drawdown Comparison

The maximum NGNE drawdown since its inception was -98.34%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for NGNE and META.

Drawdown Indicators

	NGNE	META	Difference
Max Drawdown Largest peak-to-trough decline	-98.34%	-76.74%	-21.60%
Max Drawdown (1Y) Largest decline over 1 year	-52.37%	-33.30%	-19.07%
Max Drawdown (5Y) Largest decline over 5 years	-97.20%	-76.74%	-20.46%
Max Drawdown (10Y) Largest decline over 10 years	-98.14%	-76.74%	-21.40%
Current Drawdown Current decline from peak	-95.45%	-27.41%	-68.04%
Average Drawdown Average peak-to-trough decline	-67.40%	-15.19%	-52.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.38%	13.13%	+15.25%

Volatility

NGNE vs. META - Volatility Comparison

Neurogene Inc (NGNE) has a higher volatility of 22.23% compared to Meta Platforms, Inc. (META) at 13.64%. This indicates that NGNE's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NGNE	META	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.23%	13.64%	+8.59%
Volatility (6M) Calculated over the trailing 6-month period	66.32%	26.73%	+39.59%
Volatility (1Y) Calculated over the trailing 1-year period	108.56%	39.91%	+68.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	92.98%	43.77%	+49.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.46%	38.46%	+49.00%

Financials